Author

O. A. Olajide

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:proteomics· 2

Frequent Co-Authors

A. A. Al-Hindawi· 2 shared V. U. Iwuanyanwu· 2 shared H. L. Sharp· 1 shared I. Lepairz-Raba· 1 shared I. Lepiarz-Raba· 1 shared M. A. Aderogba· 1 shared R. J. Nash· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

7 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

A. A. Al-Hindawi

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Garcinia kola and garcinoic acid suppress SARS-CoV-2 spike glycoprotein S1-induced hyper-inflammation in human PBMCs through inhibition of NF-κB activation

O. A. Olajide, V. U. Iwuanyanwu, I. Lepairz-Raba, A. A. Al-Hindawi, M. A. Aderogba, H. L. Sharp, R. J. Nash

This study shows Garcinia kola extract and garcinoic acid reduce SARS-CoV-2 spike glycoprotein S1-induced inflammation in human PBMCs by inhibiting NF-κB activation.

bioRxiv · May 18, 2021Pharmacology & Toxicology

Induction of exaggerated cytokine production in human peripheral blood mononuclear cells by a recombinant SARS-CoV-2 spike glycoprotein S1 and its inhibition by dexamethasone

O. A. Olajide, V. U. Iwuanyanwu, I. Lepiarz-Raba, A. A. Al-Hindawi

This study shows that SARS-CoV-2 spike glycoprotein S1 induces cytokine production in PBMCs, which is inhibited by dexamethasone, suggesting its anti-inflammatory role in reducing cytokine storm.

bioRxiv · Feb 3, 2021Pharmacology & Toxicology